Core Points - Acolyte's stock price decreased by 2.03% on November 14, trading at 41.95 CNY per share with a market capitalization of 4.099 billion CNY [1] - The company has seen a year-to-date stock price increase of 0.12%, with a 5-day increase of 5.11% and a 20-day increase of 5.80%, but a 60-day decline of 6.78% [1] - Acolyte's main business includes the research, production, and sales of chemical new materials, with revenue composition of 59.70% from fatty amines and 40.01% from optical materials [1] Financial Performance - For the period from January to September 2025, Acolyte reported revenue of 337 million CNY, a year-on-year decrease of 7.46%, and a net profit attributable to shareholders of -16.39 million CNY, a decrease of 141.59% [2] - The company has distributed a total of 198 million CNY in dividends since its A-share listing, with 53.54 million CNY distributed over the last three years [3] Shareholder Information - As of September 30, Acolyte had 8,766 shareholders, an increase of 46.74% from the previous period, while the average number of circulating shares per person decreased by 31.85% to 10,917 shares [2]
阿科力跌2.03%,成交额2836.21万元,主力资金净流出319.19万元